26 June 2015
Novel brightening active that evensout the skin tone for a fair and radiant complexion.
Mechanism of action
Reduces both the production and the deposition of melanin in the skin by targeting key steps of pigmentation process: regulates the gene expression of melanogenic signaling proteins, reduces tyrosinase levels and activity as well as diminishes melanin uptake by keratinocytes.
Improved luminosity and reduced dark spots for an even and brighter skin complexion. The integral approach showed a decrease in melanin content in dark spots by 61.1% (8 weeks, 2%).
Feel free to contact us for further product information.
InterMed is the exclusive agent in Malaysia for brighlette™